(Q74082709)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918427%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918427%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

Avigan D

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918427%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Wu Z

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918427%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Joyce R

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918427%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Elias A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918427%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Richardson P

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918427%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

McDermott D

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918427%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Levine J

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918427%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Kennedy L

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918427%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Giallombardo N

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918427%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Hurley D

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918427%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Gong J

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918427%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Kufe D

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918427%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 July 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918427%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

8 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918427%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918427%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918427%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

169-176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918427%20AND%20SRC:MED&resulttype=core&format=json

Hematopoietic progenitor cell transplantation in breast cancer: current status and future directions

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702474

7 January 2021

High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702474

7 January 2021

Immunologic reconstitution following stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702474

7 January 2021

THE PHENOTYPE AND RECONSTITUTION OF IMMUNOREGULATORY T CELL SUBSETS AFTER T CELL-DEPLETED ALLOGENEIC AND AUTOLOGOUS BONE MARROW TRANSPLANTATION

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702474

7 January 2021

Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702474

7 January 2021

ALTERED IMMUNOLOGIC RECONSTITUTION AFTER STANDARD-DOSE CHEMOTHERAPY OR HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE MARROW SUPPORT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702474

7 January 2021

Prolonged impairment of very late activating antigen-mediated T cell proliferation via the CD3 pathway after T cell-depleted allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702474

7 January 2021

Recovery of immunoglobulin isotypes following T-cell depleted allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702474

7 January 2021

The dendritic cell system and its role in immunogenicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702474

7 January 2021

The hematopoietic development of dendritic cells: a distinct pathway for myeloid differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702474

7 January 2021

The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702474

7 January 2021

The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702474

7 January 2021

B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702474

7 January 2021

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702474

7 January 2021

Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702474

7 January 2021

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702474

7 January 2021

Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702474

7 January 2021

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702474

7 January 2021

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702474

7 January 2021

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702474

7 January 2021

Dendritic Cells Genetically Modified with an Adenovirus Vector Encoding the cDNA for a Model Antigen Induce Protective and Therapeutic Antitumor Immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702474

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702474

7 January 2021

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702474

7 January 2021